A1CF | APOBEC1 complementation factor | Predicted intracellular proteins
| | | | | Tissue enhanced |
AADAC | Arylacetamide deacetylase | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
AADAT | Aminoadipate aminotransferase | Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ABAT | 4-aminobutyrate aminotransferase | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ABCC6 | ATP-binding cassette, sub-family C (CFTR/MRP), member 6 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ACOT6 | Acyl-CoA thioesterase 6 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ACOX2 | Acyl-CoA oxidase 2, branched chain | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ACSM1 | Acyl-CoA synthetase medium-chain family member 1 | Enzymes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ACSM3 | Acyl-CoA synthetase medium-chain family member 3 | Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ACSM5 | Acyl-CoA synthetase medium-chain family member 5 | Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ADAMTS13 | ADAM metallopeptidase with thrombospondin type 1 motif, 13 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADRA1A | Adrenoceptor alpha 1A | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
AGMO | Alkylglycerol monooxygenase | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
AGT | Angiotensinogen (serpin peptidase inhibitor, clade A, member 8) | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ALDH1L1 | Aldehyde dehydrogenase 1 family, member L1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ANGPTL4 | Angiopoietin-like 4 | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ANGPTL6 | Angiopoietin-like 6 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AOX1 | Aldehyde oxidase 1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
APOA1 | Apolipoprotein A-I | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AQP9 | Aquaporin 9 | Predicted membrane proteins
| | | | | Tissue enhanced |
ARG1 | Arginase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
ARSE | Arylsulfatase E (chondrodysplasia punctata 1) | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ART4 | ADP-ribosyltransferase 4 (Dombrock blood group) | Blood group antigen proteins CD markers Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ASPDH | Aspartate dehydrogenase domain containing | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ASPG | Asparaginase | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
BCHE | Butyrylcholinesterase | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
C1orf168 | Chromosome 1 open reading frame 168 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C2 | Complement component 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
C2orf72 | Chromosome 2 open reading frame 72 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C4A | Complement component 4A (Rodgers blood group) | Blood group antigen proteins Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
C4B | Complement component 4B (Chido blood group) | Blood group antigen proteins Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CBS | Cystathionine-beta-synthase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
CBS | Cystathionine-beta-synthase | Predicted intracellular proteins
| | | | | Tissue enhanced |
CDO1 | Cysteine dioxygenase type 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
CFI | Complement factor I | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
CHRNA4 | Cholinergic receptor, nicotinic, alpha 4 (neuronal) | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CLDN1 | Claudin 1 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
COLEC11 | Collectin sub-family member 11 | Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CRHBP | Corticotropin releasing hormone binding protein | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CXCL2 | Chemokine (C-X-C motif) ligand 2 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CYP2C18 | Cytochrome P450, family 2, subfamily C, polypeptide 18 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CYP2C19 | Cytochrome P450, family 2, subfamily C, polypeptide 19 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CYP2J2 | Cytochrome P450, family 2, subfamily J, polypeptide 2 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
CYP39A1 | Cytochrome P450, family 39, subfamily A, polypeptide 1 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
CYP3A7 | Cytochrome P450, family 3, subfamily A, polypeptide 7 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
CYP4F11 | Cytochrome P450, family 4, subfamily F, polypeptide 11 | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CYP4F3 | Cytochrome P450, family 4, subfamily F, polypeptide 3 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
DEPDC7 | DEP domain containing 7 | Predicted intracellular proteins
| | | | | Tissue enhanced |
DNAJC25 | DnaJ (Hsp40) homolog, subfamily C , member 25 | Predicted membrane proteins
| | | | | Tissue enhanced |
ELFN1 | Extracellular leucine-rich repeat and fibronectin type III domain containing 1 | Predicted membrane proteins
| | | | | Tissue enhanced |